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SCIENTIFIC OPINION 
Scientific Opinion on Flavouring Group Evaluation 93, Revision 1 
(FGE.93Rev1) 
Consideration of sulphur containing heterocyclic compounds evaluated by 
JECFA (68th meeting) structurally related to thiazoles, thiophene, thiazoline 
and thienyl derivatives evaluated by EFSA in FGE.21Rev31 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and 
Processing Aids (CEF)2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids of the European Food Safety 
Authority was requested to consider evaluations of flavouring substances assessed since 2000 by the Joint 
FAO/WHO Expert Committee on Food Additives (the JECFA), and to decide whether further evaluation is 
necessary, as laid down in Commission Regulation (EC) No 1565/2000. The present consideration concerns a 
group of five sulphur-containing heterocyclic compounds [FL-no: 15.010, 15.126, 15.128, 15.130 and 15.131] 
evaluated by the JECFA at its 68th meeting in 2007. This revision is required owing to additional available 
genotoxicity data on 2-acetyl-2-thiazoline [FL-no: 15.010]. Since the publication of FGE.93, the substance [FL-
no: FL-no: 15.127] is no longer supported by Industry for use as a flavouring substance in Europe and will 
therefore not be considered any further. The substances were evaluated through a stepwise approach that 
integrates information on structure-activity relationships, intake from current uses, toxicological threshold of 
concern, and available data on metabolism and toxicity. The two substances 5-ethyl-4-methyl-2-(2-
methylpropyl)-thiazoline [FL-no: 15.130] and 5-ethyl-4-methyl-2-(2-butyl)-thiazoline [FL-no: 15.131], which 
are 3-thiazolines, are structural similar to two other 3-thiazolines in FGE.21Rev1 for which the Panel has 
expressed a genotoxicity concern, and accordingly the Procedure should not be applied to these two substances 
until adequate genotoxicity data become available. The Panel agrees with the application of the Procedure as 
performed by the JECFA for the remaining three substances, 2-acetyl-2-thiazoline [FL-no: 15.010], 3-
(methylthio)-methylthiophene [FL-no: 15.126] and 2-propionyl-2-thiazoline [FL-no: 15.128], of the five 
substances considered in this FGE and agrees with the JECFA conclusion, “No safety concern at estimated levels 
of intake as flavouring substances” based on the MSDI approach. Besides the safety assessment of these 
                                                     
1  On request from the European Commission, Question No EFSA-Q-2013-00180,  EFSA-Q-2013-00182,  EFSA-Q-2013-
00183, EFSA-Q-2013-00184 adopted on 24 October 2013. 
2  Panel members: Ulla Beckman Sundh, Mona-Lise Binderup, Claudia Bolognesi, Leon Brimer, Laurence Castle, 
Alessandro Di Domenico, Karl-Heinz Engel, Roland Franz, Nathalie Gontard, Rainer Gürtler, Trine Husøy, Klaus-Dieter 
Jany, Martine Kolf-Clauw, Wim Mennes, Maria Rosaria Milana, Iona Pratt, Kettil Svensson, Maria de Fatima Tavares 
Poças, Fidel Toldra and Detlef Wölfle. Correspondence: cef@efsa.europa.eu   
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Husøy, John Christian Larsen, Wim Mennes, Gerard Mulder and Harriet Wallin for the preparatory work on this scientific 
opinion and the hearing experts: Vibe Beltoft, Pia Lund and Karin Nørby and EFSA staff: Annamaria Rossi and Kim 
Rygaard Nielsen for the support provided to this scientific opinion. 
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flavouring substances, the specifications for the materials of commerce have also been considered and for all five 
substances, the information is adequate. 
 
© European Food Safety Authority, 2013 
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SUMMARY 
Following a request from the European Commission, the EFSA Panel on Food Contact Materials, 
Enzymes, Flavourings and Processing Aids (CEF Panel) was asked to deliver scientific advice to the 
Commission on the implications for human health of chemically defined flavouring substances used in 
or on foodstuffs in the Member States. In particular, the CEF Panel was requested to consider the Joint 
FAO/WHO Expert Committee on Food Additives (the JECFA) evaluations of flavouring substances 
assessed since 2000, and to decide whether no further evaluation is necessary, as laid down in 
Commission Regulation (EC) No 1565/2000. These flavouring substances are listed in the Register, 
which was adopted by Commission Decision 1999/217/EC and its consecutive amendments. 
In Flavouring Group Evaluation 93 (FGE.93), the EFSA considered six sulphur containing 
heterocyclic substances evaluated by the JECFA (68th meeting). This revision is made due to 
additional available genotoxicity data on 2-acetyl-2-thiazoline [FL-no: 15.010], as requested in 
previous version of FGE.93. For one substance [FL-no: 15.127], additional toxicity data ware 
requested in FGE.93. However, since publication of FGE.93 the substance [FL-no: 15.127] is no 
longer supported by Industry for use as a flavouring substance in Europe and will therefore not be 
considered any further. Therefore, the present revision of FGE.93, FGE.93Rev1, considers five 
flavouring substances evaluated by the JECFA. 
The Panel concluded that the five substances in the JECFA flavouring group of sulphur-containing 
heterocyclic substances are structurally related to the 59 substances evaluated by EFSA in 
FGE.21Rev3. 
The Panel agrees with the way the application of the Procedure was applied by the JECFA for three of 
the five substances, 2-acetyl-2-thiazoline [FL-no: 15.010], 3-(methylthio)-methylthiophene [FL-no: 
15.126] and 2-propionyl-2-thiazoline [FL-no: 15.128]. The remaining two substances, 5-ethyl-4-
methyl-2-(2-methylpropyl)-thiazoline [FL-no: 15.130] and 5-ethyl-4-methyl-2-(2-butyl)-thiazoline 
[FL-no: 15.131], which are 3-thiazolines, are structurally similar to two other 3-thiazolines in FGE.21 
for which the Panel has expressed a genotoxicity concern, and accordingly the Procedure should not 
be applied to these two substances until adequate genotoxicity data become available. 
Genotoxicity data have become available for 2-acetyl-2-thiazoline [FL-no: 15.010] and based on these 
new in vitro studies (gene mutation test in bacteria and micronucleus assay in human peripheral blood 
lymphocytes), the genotoxicity concern could be ruled out. 2-Acetyl-2-thiazoline [FL-no: 15.010] is 
supporting the other 2-thiazoline included in this FGE, 2-propionyl-2-thiazoline [FL-no: 15.128], thus 
the two substances can now be evaluated using the Procedure.  
For 2-acetyl-2-thiazoline [FL-no: 15.010] and 2-propionyl-2-thiazoline [FL-no: 15.128] (2-
thiazolines), the intakes (MSDI) of 0.51 and 0.19 µg/capita/day are below the threshold for their 
structural class II. The no observed adverse effect level (NOAEL) of 1.8 mg/kg body weight (bw) per 
day for 2-acetyl-2-thiazoline from a 90-day and a 52-week rat studies that examined a mixture of four 
flavouring substances, including [FL-no: 15.010], provides margins of safety of 2.1 x 105 and 5.7 x 
105, respectively, in relation to the estimated levels of exposure from their use as flavouring 
substances. The Panel agrees that this provides sufficient safety margins and that these flavouring 
substances can be concluded at step B4 in the Procedure to be of no safety concern. 
For 3-(methylthio)methylthiophene [FL-no: 15.126] the maximised survay-derived daily intake 
(MSDI) is below the threshold for its structural class (Cramer class III, 90 µg/person/day). The Panel 
agrees with the JECFA that the NOAEL of 0.29 mg/kg bw/day for the supporting substance 2-thienyl 
disulphide [FL-no: 15.008] is adequate for [FL-no: 15.126] and that it provides a sufficient safety 
margin. It can therefore be concluded that this substance is of no safety concern when used as 
flavouring substance at the estimated level of intake, based on the MSDI approach. 
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For the three substances [FL-no: 15.010, 15.126 and 15.128] evaluated through the Procedure, use 
levels have been provided by the Industry. The modified theoretical added maximumdaily intake 
(mTAMDI) figures calculated for the substances [FL-no: 15.010 and 15.128] in structural class II are 
810 and 62 µg/person/day, respectively. For substance [FL-no: 15.010] the value exceeds the 
threshold of 540 µg/person/day for structural class II. For the substance [FL-no: 15.126] in structural 
class III the mTAMDI figure is 3.8 µg/person/day, which is below the threshold of concern of 90 
µg/person/day. Although the two remaining substances [FL-no: 15.130 and 15.131] cannot be 
evaluated through the Procedure, the corresponding available use levels were considered. For the two 
substances in structural class III the figures are 160 µg/person/day, which exceeds the threshold of 
concern of 90 µg /person/day for the structural class. Thus, for three substances [FL-no: 15.010, 
15.130 and 15.131] the intakes, estimated on the basis of the mTAMDI approach, exceed the threshold 
for their structural classes. Therefore more reliable exposure data are required. On the basis of such 
additional data, these flavouring substances should be considered using the Procedure. Subsequently, 
additional data might become necessary. 
In order to determine whether the conclusion for the five JECFA evaluated substances can be applied 
to the materials of commerce, it is necessary to consider the available specifications. Adequate 
specifications including complete purity criteria and identity tests are available for all five JECFA-
evaluated substances. 
Thus, the Panel concluded that the three substances [FL-no: 15.010, 15.126 and 15.128] are of no 
safety concern at the estimated intake. For the remaining two substances [FL-no: 15.130 and 15.131] 
the Panel concluded that the Procedure could not be applied pending submission and evaluation of 
genotoxicity data. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The use of flavourings is regulated under Regulation (EC) No 1334/2008 of the European Parliament 
and Council of 16 December 20084 on flavourings and certain food ingredients with flavouring 
properties for use in and on foods. On the basis of Article 9(a) of this Regulation, an evaluation and 
approval are required for flavouring substances. 
The Union list of flavourings and source materials was established by Commission Implementing 
Regulation (EC) No 872/20125. The list contains flavouring substances for which the scientific 
evaluation should be completed in accordance with Commission Regulation (EC) No 1565/20006. 
EFSA has evaluated the flavouring substance 2-methyl-2-thiazoline [FL-no: 15.086] in the Flavouring 
Group Evaluation 21 (FGE.21). The opinion was adopted on 8 February 2007. EFSA concluded in its 
opinion that adequate genotoxicity data is required. 
EFSA has considered the Joint FAO/WHO Expert Committee on Food Additives (the JECFA) 
evaluation of six sulphur containing hetereocyclic substances in the Flavouring Group Evaluation 93 
(FGE.93). The Opinion was adopted on 23 July 2009. EFSA concluded in its opinion that for four 
substances, 2-acetyl-2-thiazoline [FL-no: 15.010], 2-propionyl-2-thiazoline [FL-no: 15.128], 5-ethyl-
4-methyl-2-(2-methylpropyl)-thiazoline [FL-no: 15.130] and 5-ethyl-4-methyl-2-(2-butyl)-thiazoline 
[FL-no: 15.131] adequate genotoxicity data is required.  
The requested information on one representative material, 2-acetyl-2-thiazoline [FL-no: 15.010] has 
now been submitted by the European Flavour Association. This information is intended to cover re-
evaluation of this substance and of the three substances [FL-no: 15.128, 15.130 and 15.131] in 
FGE.93Rev1. In addition, it should cover the re-evaluation of 2-methyl-2-thiazoline [FL-no: 15.086] 
from FGE.21. 
The Commission asks EFSA to evaluate this new information and depending on the outcome proceed 
to the full evaluation of the flavouring substances.  
 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The European Commission requests EFSA to carry out a safety assessment on the following five 
flavouring substances: 2-acetyl-2-thiazoline [FL-no: 15.010], 2-methyl-2-thiazoline [FL-no: 15.086], 2-
propionyl-2-thiazoline [FL-no: 15.128], 5-ethyl-4-methyl-2-(2-methylpropyl)-thiazoline [FL-no: 15.130] 
and 5-ethyl-4-methyl-2-(2-butyl)-thiazoline [FL-no: 15.131] in accordance with Commission Regulation 
(EC) N° 1565/2000. 
                                                     
4  Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and  
 certain food ingredients with flavouring properties for use in and on foods and amending Council Regulation (EEC) No  
 1601/91, Regulations (EC) No 2232/96 and (EC) No 110/2008 and Directive 2000/13/EC. Official Journal of the European  
 Communities 31.12.2008, L 354/34-50. 
5  EC (European Commission), 2012. Commission implementing Regulation (EU) No 872/2012 of 1 October 2012 adopting  
 the list of flavouring substances provided for by Regulation (EC) No 2232/96 of the European Parliament and of the  
 Council, introducing it in Annex I to Regulation (EC) No 1334/2008 of the European Parliament and of the Council and  
 repealing Commission Regulation (EC) No 1565/2000 and Commission Decision 1999/217/EC. Official Journal of the  
 European Communities 2.10.2012, L 267, 1-161.OJ L 267, 2.10.2012, p. 1. 
6  Commission Regulation No 1565/2000 of 18 July 2000 laying down the measures necessary for the adoption of an  
 evaluation programme in application of Regulation (EC) No 2232/96. Official Journal of the European Communities  
 19.7.2000, L 180, 8-16. 
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ASSESSMENT 
The approach used by EFSA for safety evaluation of flavouring substances is referred to in 
Commission Regulation (EC) No 1565/2000, hereafter named the “EFSA Procedure”. This Procedure 
is based on the Opinion of the Scientific Committee on Food (SCF, 1999), which has been derived 
from the evaluation procedure developed by the Joint FAO/WHO Expert Committee on Food 
Additives (JECFA, 1995; JECFA, 1996; JECFA, 1997; JECFA, 1999), hereafter named the “JECFA 
Procedure”. The Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (the 
Panel) compares the JECFA evaluation of structurally related substances with the result of a 
corresponding EFSA evaluation, focussing on specifications, intake estimations and toxicity data, 
especially genotoxicity data. The evaluations by EFSA will conclude whether the flavouring 
substances are of no safety concern at their estimated levels of intake, whether additional data are 
required or whether certain substances should not be evaluated through the EFSA Procedure. 
The following issues are of special importance. 
Intake 
In its evaluation, the Panel as a default uses the maximised survey-derived daily intake (MSDI) 
approach to estimate the per capita intakes of the flavouring substances in Europe.  
In its evaluation, the JECFA includes intake estimates based on the MSDI approach derived from both 
European and USA production figures. The highest of the two MSDI figures is used in the evaluation 
by the JECFA. It is noted that in several cases, only the MSDI figures from the USA were available, 
meaning that certain flavouring substances have been evaluated by the JECFA only on the basis of 
these figures. For Register substances for which this is the case the Panel will need EU production 
figures in order to finalise the evaluation. 
When the Panel examined the information provided by the European Flavour Industry on the use 
levels in various foods, it appeared obvious that the MSDI approach in a number of cases would 
grossly underestimate the intake by regular consumers of products flavoured at the use level reported 
by the Industry, especially in those cases where the annual production values were reported to be 
small. In consequence, the Panel had reservations about the data on use and use levels provided and 
the intake estimates obtained by the MSDI approach. It is noted that the JECFA, at its 65th meeting 
considered ”how to improve the identification and assessment of flavouring agents, for which the 
MSDI estimates may be substantially lower than the dietary exposures that would be estimated from 
the anticipated average use levels in foods” (JECFA, 2006). 
In the absence of more accurate information that would enable the Panel to make a more realistic 
estimate of the intakes of the flavouring substances, the Panel has decided to also perform an estimate 
of the daily intakes per person using a modified theoretical added maximum Ddaily Intake (mTAMDI) 
approach based on the normal use levels reported by Industry. 
As information on use levels for the flavouring substances has not been requested by the JECFA or 
has not otherwise been provided to the Panel, it is not possible to estimate the daily intakes using the 
mTAMDI approach for the substances evaluated by the JECFA. The Panel will need information on 
use levels in order to finalise the evaluation. 
Threshold of 1.5 Microgram/Person/Day (Step B5) Used by the JECFA 
The JECFA uses the threshold of concern of 1.5 microgram (µg)/person/day as part of the evaluation 
procedure: 
“The Committee noted that this value was based on a risk analysis of known carcinogens which 
involved several conservative assumptions. The use of this value was supported by additional 
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information on developmental toxicity, neurotoxicity and immunotoxicity. In the judgement of the 
Committee, flavouring substances for which insufficient data are available for them to be evaluated 
using earlier steps in the Procedure, but for which the intake would not exceed 1.5 µg per person per 
day would not be expected to present a safety concern. The Committee recommended that the 
Procedure for the Safety Evaluation of Flavouring Agents used at the forty-sixth meeting be amended 
to include the last step on the right-hand side of the original procedure (“Do the condition of use result 
in an intake greater than 1.5 µg per day?”)” (JECFA, 1999).  
In line with the Opinion expressed by the Scientific Committee on Food (SCF, 1999), the Panel does 
not make use of this threshold of 1.5 µg per person per day. 
Genotoxicity 
As reflected in the Opinion of SCF (SCF, 1999), the Panel has in its evaluation focussed on a possible 
genotoxic potential of the flavouring substances or of structurally related substances. Generally, 
substances for which the Panel has concluded that there is an indication of genotoxic potential in vitro, 
will not be evaluated using the EFSA Procedure until further genotoxicity data are provided. 
Substances for which a genotoxic potential in vivo has been concluded, will not be evaluated through 
the Procedure. 
Specifications 
Regarding specifications, the evaluation by the Panel could lead to a different opinion than that of 
JECFA, since the Panel requests information on e.g. isomerism. 
Structural Relationship  
In the consideration of the JECFA evaluated substances, the Panel will examine the structural 
relationship and metabolism features of the substances within the flavouring group and compare this 
with the corresponding FGE. 
1. HISTORY OF THE EVALUATION OF THE SUBSTANCES IN THE PRESENT FGE  
In FGE.93, which contains a group of six flavouring substances consisting of sulphur-containing 
heterocyclic substances, the Panel concluded that for four substances [FL-no: 15.010, 15.128, 15.130 
and 15.131], the Procedure should not be applied until adequate genotoxicity data become available 
and for one substance [FL-no: 15.127] lack of toxicity information prevented its final evaluation 
through the Procedure. 
Industry has informed that the substance 1-(3-hydroxy-5-methyl-2-thienyl)ethanone [FL-no: 15.127] is 
no longer supported for use as a flavouring substance in Europe (EFSA, 2011) and the substance will 
therefore not be considered any further.  
FGE Opinion adopted Link No. of substances 
FGE.93 23 July 2009 http://www.efsa.europa.eu/en/efsajournal/pub/1206.htm 6 
FGE.93Rev1 24 October 2013  5 
 
The present revision of FGE.93 (FGE.93Rev1) concerns the re-consideration of the four JECFA-
evaluated substances [FL-no: 15.010, 15.128, 15.130 and 15.131] considered in FGE.93. 
Additional data, genotoxicity studies (in vitro reverse mutation and micronucleus assays) on 2-acetyl-
2-thiazoline [FL-no: 15.010] and new tonnage figures for two substances [FL-no: 15.010 and 15.128] 
(EFFA, 2012)  have now become available. Furthermore, new information from Industry on missing 
stereoisomeric composition for [FL-no: 15.130 and 15.131] (EFFA, 2013a) and information on 
specifications for [FL-no: 15.126 and 15.128] (EFFA, 2013b) is also included in the present revision. 
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In the document on “Representative substances for testing” (EFSA CEF Panel, 2012a), substance 2-
acetyl-2-thiazoline [FL-no: 15.010] was identified as a supporting substance with respect to 
genotoxicity for 2-methyl-2-thiazoline [FL-no: 15.086] included in FGE.21, and for 2-propionyl-2-
thiazoline [FL-no: 15.128], 5-ethyl-4-methyl-2-(2-methylpropyl)-thiazoline [FL-no: 15.130] and 5-
ethyl-4-methyl-2-(2-butyl)-thiazoline [FL-no: 15.131] included in FGE.93. However, [FL-no: 15.130 
and FL-no: 15.131] which in the document “Representative substances for testing” were grouped with 
2-thiazolines are in fact 3-thiazolines and should have been grouped together with 2-(sec-butyl)-4,5-
dimethyl-3-thiazoline [FL-no: 15.029], 4,5-dimethyl-2-ethyl-3-thiazoline [FL-no: 15.030] and 4,5-
dimethyl-2-isobutyl-3-thiazoline [FL-no: 15.032] included in FGE.76 and together with 2,4-dimethyl-
3-thiazoline [FL-no: 15.060] and 2-isobutyl-3-thiazoline [FL-no: 15.119] included in FGE.21. For the 
group of 3-thiazolines, 4,5-dimethyl-2-isobutyl-3-thiazoline [FL-no: 15.032] was identified as a 
supporting substance with respect to genotoxicity. Therefore,  5-ethyl-4-methyl-2-(2-methylpropyl)-
thiazoline [FL-no: 15.130] and 5-ethyl-4-methyl-2-(2-butyl)-thiazoline [FL-no: 15.131] included in 
FGE.93, will be evaluated by the Panel together with the other 3-thiazolines when the requested 
genotoxicity studies on 4,5-dimethyl-2-isobutyl-3-thiazoline [FL-no: 15.032] become available. 
2. PRESENTATION OF THE SUBSTANCES IN THE JECFA FLAVOURING GROUP 
2.1. Description 
2.1.1. JECFA Status 
The JECFA has evaluated a group of 17 flavouring substances consisting of sulphur-containing 
heterocyclic substances at its 68th meeting (JECFA, 2007; JECFA, 2008a). 
2.1.2. EFSA Considerations 
The current FGE.93Rev1 deals with five [FL-no: 15.010, 15.126, 15.128, 15.130, 15.131] of the 17 
substances evaluated by the JECFA (JECFA, 2008a). 
• Seven of the substances evaluated by the JECFA in 2008 are not in the Register [2-(4-methyl-
5-thiazolyl)ethyl formate, 2-(4-methyl-5-thiazolyl)ethyl propionate, 2-(4-methyl-5-
thiazolyl)ethyl butanoate, 2-(4-methyl-5-thiazolyl)ethyl isobutyrate, 2-(4-methyl-5-
thiazolyl)ethyl hexanoate, 2-(4-methyl-5-thiazolyl)ethyl octanoate, 2-(4-methyl-5-
thiazolyl)ethyl decanoate (JECFA-no: 1751-1757).  
• Four other substances have been evaluated by the AFC Panel of EFSA (before the JECFA) in 
FGE.21 [FL-no: 15.063, 15.055, 15.076 and 15.114] (JECFA-no: 1758, 1763, 1764 and 1766).  
• Industry has informed that substance [FL-no: 15.127] (JECFA-no: 1750) is no longer 
supported for use as a flavouring substance in Europe  and the substance will therefore not be 
considered any further. 
This consideration therefore only deals with five substances [FL-no: 15.010, 15.126,  15.128, 15.130, 
15.131].  
The Panel concluded that these five substances of the JECFA flavouring group of sulphur containing 
heterocyclic substances are structurally related to the group of thiazoles, thiophene, thiazoline and 
thienyl derivatives evaluated by EFSA in the Flavouring Group Evaluation 21, Revision 3 
(FGE.21Rev3)7 (EFSA CEF Panel, 2012). The substances in FGE.21Rev3 were subdivided into a 
number of subgroups. The five substances in the current FGE.93Rev1 are assigned to the following 
two FGE.21 subgroups:  
                                                     
7  The Panel is aware that for FGE.21, a revision 4 has been released. For the candidate substances in subgroups B-II and B-III of  
 FGE.21Rev3, a concern with respect to genotoxicity was raised. This concern is also applicable to candidate substances [FL no: 15.130  
 and 15.131] in FGE.93. Since in revision 4 of FGE.21 subgroup B-III has been removed, in order to facilitate the identification of the  
 reason for this concern for these two substances in FGE.93, reference to FGE.21Rev3 is maintained, rather than to FGE.21Rev4. 
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• 3-(Methylthio)-methylthiophen [FL-no: 15.126] in subgroup A-Ic.  
• 2-Acetyl-2-thiazoline [FL-no: 15.010], 2-propionyl-2-thiazoline [FL-no 15.128], 5-ethyl-4-
methyl-2-(2-methylpropyl)-thiazoline [FL-no: 15.130] and 5-ethyl-4-methyl-2-(2-butyl)-
thiazoline [FL-no: 15.131] in subgroup B-II. 
 
2.2. Isomers 
2.2.1. Status 
The following two substances [FL-no: 15.130 and 15.131] in the group of the JECFA evaluated 
sulphur containing heterocyclic substances have chiral centres. 
2.2.2. EFSA Considerations 
Adequate information on isomeric composition is available for the two isomeric substances [FL-no: 
15.130 and 15.131] (Table 1). 
2.3. Specifications 
2.3.1. Status 
The European Flavour Industry has submitted specifications for the substances commercially used in 
Europe (EFFA, 2006a; EFFA, 2006b; Flavour Industry, 2004; Flavour Industry, 2005). Although the 
JECFA specifications are available, the specifications used in this consideration are those submitted by 
the Industry (See Table 3). 
2.3.2. EFSA Considerations 
Specifications including complete purity criteria and identity tests are available for all substances. 
3. INTAKE ESTIMATION 
3.1. JECFA Status 
For all five substances evaluated through the JECFA Procedure intake data (MSDI) are available for 
EU. 
3.2. EFSA Considerations 
For all the JECFA-evaluated substances normal and maximum use levels have been provided by the 
Flavour Industry [FL-no: 15.010, 15.126, 15.128, 15.130 and 15.131] (EFFA, 2006a; EFFA, 2006b; 
EFFA, 2007; Flavour Industry, 2005) (see Table 1). Based on these normal use levels, mTAMDI 
figures (see Table 2) can be calculated. For definition of normal and maximum use levels and 
description of the method for calculation of mTAMDI consult Annex II in e.g. (EFSA, 2004). 
 
Table 1:  Normal and Maximum use levels (mg/kg) available for the JECFA evaluated substances in 
FGE.93Rev1 
FL-no Food Categories 
Normal use levels (mg/kg) 
Maximum use levels (mg/kg) 
01.0 02.0 03.0 04.1 04.2 05.0 06.0 07.0 08.0 09.0 10.0 11.0 12.0 13.0 14.1 14.2 15.0 16.0 
15.010 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
4 
2 
0,2 
1 
4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
4 
2 
1 
5 
0,2 
1 
15.126 0,01 
0,1 
0,01 
0,1 
- 
- 
0,005 
0,05 
- 
- 
- 
- 
- 
- 
0,02 
0,2 
0,005 
0,05 
- 
- 
- 
- 
- 
- 
0,005 
0,05 
- 
- 
- 
- 
- 
- 
0,05 
0,5 
0,01 
0,1 
15.128 0,16 
0,8 
0,04 
0,2 
0,16 
0,8 
- 
- 
- 
- 
0,04 
0,2 
0,01 
0,05 
0,4 
1 
0,04 
0,4 
- 
- 
- 
- 
- 
- 
0,08 
0,8 
- 
- 
0,01 
0,08 
0,04 
0,2 
0,08 
0,8 
- 
- 
15.130 - 0,2 0,4 0,3 - 0,4 0,2 0,4 0,1 0,1 - - 0,2 0,4 0,2 0,4 1 0,2 
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- 1,1 2 1,5 - 2 1 2 0,4 0,4 - - 1 2 1 2 5 1 
15.131 0,4 
2 
0,2 
1 
0,4 
2 
0,3 
1,5 
- 
- 
0,4 
2 
0,2 
1 
0,4 
2 
0,1 
0,4 
0,1 
0,4 
- 
- 
- 
- 
0,2 
1 
0,4 
2 
0,2 
1 
0,4 
2 
1 
5 
0,2 
1 
 
Table 2:  Estimated intakes based on the MSDI approach and the mTAMDI approach 
FL-no EU Register name MSDI – EU 
(μg/capita/day) 
MSDI – USA 
(μg/capita/day) 
mTAMDI 
(μg/person/day) 
Structural 
class 
Threshold of concern 
(µg/person/day) 
15.010 2-Acetyl-2-thiazoline 0.51 ND 810 Class II 540 
15.127 1-(3-Hydroxy-5-methyl-2-
thienyl)ethanone 
0.012 ND ND Class II 540 
15.128 2-Propionyl-2-thiazoline 0.19 ND 62 Class II 540 
15.126 3-(Methylthio)-methylthiophen 0.012 ND 3.8 Class III 90 
15.130 5-Ethyl-4-methyl-2-(2-methylpropyl)-
thiazoline 
0.012 ND 160 Class III 90 
15.131 5-Ethyl-4-methyl-2-(2-butyl)-
thiazoline 
0.012 ND 160 Class III 90 
ND) Not determined. 
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SUMMARY OF SPECIFICATION DATA 
Table 3:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2008b) 
FL-no 
JECFA-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in 
ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
EFSA comments 
15.010 
1759 
2-Acetyl-2-thiazoline S
N
O
 
3817 
2335 
29926-41-8 
Solid 
C5H7NOS 
129.18 
Practically 
insoluble or 
insoluble 
Soluble 
 
27 
IR NMR MS 
98 % 
n.a. 
n.a. 
 
(EFFA, 2006b). 
15.126 
1765 
3-(Methylthio)-
methylthiophen 
S
S  
 
 
61675-72-7 
Liquid 
C6H8S2 
144.26 
Slightly soluble 
Slightly soluble 
210-211 
n.a. 
IR NMR MS 
97 % 
1.580-1.586 
1.522-1.528 
 
(EFFA, 2006a). 
Register name to be 
changed to 3-
(methylthio)-
methylthiophene. 
15.127 
1750 
1-(3-Hydroxy-5-methyl-2-
thienyl)ethanone S
OH
O
 
4142 
 
133860-42-1 
Solid 
C7H8O2S 
156.2 
Slightly soluble 
Soluble 
 
74.3 (969 hPa) 
IR NMR MS 
98.3 % 
n.a. 
n.a. 
 
(Flavour Industry, 
2004). Substance no 
longer supported by 
Industry (EFSA, 
2011). 
15.128 
1760 
2-Propionyl-2-thiazoline 
N
S
O
 
4064 
 
29926-42-9 
Liquid 
C6H9NOS 
143.21 
Insoluble 
Soluble 
237-241 
 
IR NMR MS 
99 % 
1.510-1.525 
1.130-1.330 
 
(EFFA, 2006a). 
15.130 
1761 
5-Ethyl-4-methyl-2-(2-
methylpropyl)-thiazoline S
N
 
4319 
 
83418-53-5 
Liquid 
C10H19NS 
185.33 
Soluble 
Soluble 
253 
 
NMR MS 
95 % 
1.483-1.489 
0.939-0.945 
 
(Flavour Industry, 
2005).   
Industry: cis- and 
trans-5-Ethyl-4-
methyl-2-(2-
methylpropyl)-
thiazoline.  
Mixture of 
diastereoisomers, each 
of them racemic 
(EFFA, 2013a). 
15.131 
1762 
5-Ethyl-4-methyl-2-(2-
butyl)-thiazoline 
S
N
 
4318 
 
83418-54-6 
Liquid 
C10H19NS 
185.33 
Soluble 
Soluble 
253 
 
NMR MS 
95 % 
1.487-1.493 
0.950-0.956 
 
(Flavour Industry, 
2005).  
Mixture of 
diastereoisomers, each 
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Table 3:  Specification Summary of the Substances in the JECFA Flavouring Group (JECFA, 2008b) 
FL-no 
JECFA-no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in 
ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
EFSA comments 
of them racemic 
(EFFA, 2013a). 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 % ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
 
 
F
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4. GENOTOXICITY DATA 
4.1. Genotoxicity Studies – Text Taken8 from the JECFA Report (JECFA, 2008a) 
Thiophene [FL-no: 15.106] (structurally related substance) 
The results of several in vitro tests for genotoxicity conducted with thiophene, a structurally related 
substance, are described below.  
No increase in mutagenic activity was observed in the reverse mutation assay (Ames test) in 
Salmonella typhimurium strains TA98, TA100, TA1535 or TA1537 at 0, 78.1, 156, 313, 625, 1250, 
2500 or 5000 μg thiophene/plate with and without metabolic activation. Toxicity was noted at 1500 
μg/plate in TA1537 and at 2500 μg/plate in TA98, TA100 and TA1535 (Shibuya, 2006). 
Similarly, there was no increase in mutagenic activity in a mutation assay in Escherichia coli strain 
WP2uvrA at 0, 313, 625, 1250, 2500 or 5000 μg/plate with and without metabolic activation. Toxicity 
was noted at the 5000 μg/plate concentration (Shibuya, 2006). 
There was no increase in chromosomal aberrations or polyploidy following incubation of Chinese 
hamster lung cells with 0, 210, 420 or 840 μg thiophene/ml (Tanaka, 2006). 
Conclusion on genotoxicity 
No genotoxicity data were available on the 17 sulphur containing hetereocyclic substances evaluated 
by the JECFA at its 68th meeting. The JECFA evaluation refers to data on thiophene only, as 
summarised in Table 4. The JECFA concluded that in its previous evaluation of substances in this 
group (JECFA, 2003), studies on genotoxicity, as well as studies on acute toxicity and short-term 
toxicity were available and none raised safety concerns. 
4.2. Genotoxicity Studies – Text Taken9 from EFSA FGE.21Rev3 (EFSA, 2012b) 
Genotoxicity data were provided for 12 candidate substances. These 12 substances belong to subgroup 
A-Ia: thiophene [FL-no: 15.106]; subgroup A-Ib: 2-methylthiophene [FL-no: 15.091], 3-
methylthiophene [FL-no: 15.092], 2,5-dimethylthiophene [FL-no: 15.064], 2-acetylthiophene [FL-no: 
15.040], 2-acetyl-3-methylthiophene [FL-no: 15.037], thiophene-2-carbaldehyde [FL-no: 15.107], 5-
ethylthiophene-2-carbaldehyde [FL-no: 15.074]; subgroup A-II: 2,4-dimethylthiazole [FL-no: 15.062]; 
subgroup A-III: 2-methyl-4,5-benzothiazole [FL-no: 15.088]; subgroup B-III: 2-methylthiazolidine 
[FL-no: 15.090] and 2-propylthiazolidine [FL-no: 15.099]. There were also mutagenicity data on four 
supporting substances and on four other structurally related substances. All available information on 
genotoxicity of the 12 candidate and the four supporting substances and of four other structurally 
related substances is based upon in vitro studies only. 
In the following text from FGE.21Rev3 (EFSA, 2012b), only the information for subgroup A-I, B-I, 
B-II and B-III has been presented, as the information for subgroups A-II and A-III, B-IV, B-V and B-
VI was not relevant to the candidate substances in the current FGE. 
Subgroup A-I: Thiophenes 
Thiophene [FL-no: 15.106], 2-methylthiophene [FL-no: 15.091], 3-methylthiophene [FL-no: 15.092] 
and 2,5-dimethylthiophene [FL-no: 15.064] were reported to be negative in microbial mutagenicity 
assays. 2-Acetylthiophene [FL-no: 15.040] was negative in microbial tests, using Salmonella 
typhimurium strains TA98 and TA100, with and without metabolic activation and in the SOS 
chromotest with metabolic activation. 2-Acetylthiophene was reported to be positive without 
metabolic activation in the SOS Escherichia coli chromotest (Mosier et al., 2003). In the same study, 
                                                     
8 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present FGE has been removed. 
9 The text is taken verbatim from the indicated reference source, but text related to substances not included in the present FGE has been removed. 
F
 
EFSA Journal 2013;11(11):3452 15
2-acetyl-3-methylthiophene [FL-no: 15.037], thiophene-2-carbaldehyde [FL-no: 15.107] and 5-
ethylthiophene-2-carbaldehyde [FL-no: 15.074] gave positive results without metabolic activation in 
the SOS E. coli chromotest. The concentrations tested were not reported for any of the substances 
subjected to the SOS E. coli chromotest (Mosier et al., 2003). The Panel considered the endpoint of 
this test inappropriate for the estimation of genotoxic potential. The supporting substance 5-methyl-2-
thiophenecarbaldehyde [FL-no: 15.004] was negative in a microbial mutagenicity assay. 
Thiophene was tested in accordance to OECD guidelines in a bacterial reverse mutation test in strains 
of S. typhimurium and in strain WP2 uvrA of E. coli. No evidence of mutagenic response was reported 
when strains TA100, TA1535, TA98 and TA1537 of S. typhimurium were incubated at concentrations 
of 0, 78.1, 156, 313, 625, 1250, 2500 and 5000 μg/plate with and without S9 metabolic activation. 
Toxicity was observed at 1250 μg/plate in TA1537, and 2500 μg/plate in strains TA100, TA1535 and 
TA98 also with and without metabolic activation. Toxicity was observed at 5000 μg/plate in WP2 with 
and without S9 metabolic activation (Shibuya, 2006). 
In a chromosomal aberration test, thiophene was tested on Chinese hamster lung cells in accordance 
with Japanese Guidelines. No chromosomal aberrations or polyploidy was reported when incubated 
with concentrations of 0, 210, 420, 840 μg/mL of thiophene, with and without metabolic activity 
(Tanaka, 2006). 
Subgroups B-I and B-II: Dihydrothiophenes and thiazolines 
No genotoxicity information was available for any candidate or supporting substances in these 
subgroups. However, considering the structural similarities between the thiazolines in subgroup B-II 
and the thiazolidines in subgroup B-III, the Panel also concluded that the thiazolines [FL-no: 15.060, 
15.086 and 15.119] could not be evaluated through the Procedure (see Subgroup B-III below). 
Subgroup B-III: Thiazolidines 
The two candidate substances 2-methylthiazolidine [FL-no: 15.090] and 2-propylthiazolidine [FL-no: 
15.099] as well as the structurally related ethyl, isopropyl, n-butyl and isobutyl thiazolidine have all 
been reported to be positive in the Ames tests (TA98 and TA100) (Mihara and Shibamoto, 1980). 
Owing to limited reporting, the data could not be properly evaluated. Nevertheless, these reports do 
raise the possibility of a genotoxic potential of these thiazolidines. Accordingly, it was concluded not 
to evaluate the candidate substances 2-methylthiazolidine and 2-propylthiazolidine through the 
Procedure. 
Conclusion on genotoxicity 
It is concluded that the genotoxicity data are limited and that genotoxicity could not be assessed 
adequately for the flavouring substances in the present revision of FGE.21, Revision 3. However, 
except for the two dihydrothiazines, 6-acetyl-2,3-dihydro-1,4-thiazine [FL-no: 15.114] (Register 
name: 5-acetyl-2,3-dihydro-1,4-thiazine) and 5-acetyl-2,3-dihydro-1,4-thiazine [FL-no: 15.133], the 
two thiazolidines 2-methylthiazolidine [FL-no: 15.090] and 2-propylthiazolidine [FL-no: 15.099] and 
the three structurally related thiazolines 2-methyl-2-thiazoline [FL-no: 15.086], 2,4-dimethyl-3-
thiazoline [FL-no: 15.060] and 2-isobutyl-3-thiazoline [FL-no: 15.119], the genotoxicity data available 
do not preclude the evaluation of the remaining 49 candidate substances using the Procedure. 
For a summary of in vitro genotoxicity data considered by EFSA, see Table 4. 
4.3. New Genotoxicity Studies on 2-Acetyl-2-thiazoline [FL-no: 15.010] 
In vitro 
2-Acetyl-2-thiazoline [FL-no: 15.010] was tested for the induction of gene mutations in Salmonella 
typhimurium strains TA98, TA100, TA1535, TA1537 and TA102 both in the presence and absence of 
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Aroclor 1254 induced rat liver S9-mix. Two independent experiments were carried out (Mc Garry, 
2012).  
In the first experiment, 2-acetyl-2-thiazoline was tested in all five strains in the absence and presence 
of S9-mix using the plate incorporation methodology at concentrations of 5, 15.8, 50, 158.1, 500, 1581 
and 5000 μg/plate. No evidence of toxicity was observed in any strains at any concentration tested. 
In the second experiment, the concentrations of 2-acetyl-2-thiazoline used in all strains in the absence 
and presence of S9-mix were 156.3, 312.5, 625.0, 1250, 2500 and 5000 μg/plate of 2-acetyl-2-
thiazoline, and the pre-incubation method was used for treatments in the presence of S-9. No evidence 
of toxicity was observed in any strains at any concentration tested. 
No statistically significant increases in revertant numbers were observed in any of the tester strains 
that were both concentration-related and clearly reproducible. 
It is concluded that 2-acetyl-2-thiazoline [FL-no: 15.010] did not induce mutations in five histidine-
requiring strains (TA98, TA100, TA1535, TA1537 and TA102) of S. typhimurium when tested under 
the conditions of the study (Table 5). The study was conducted using GLP and the design complied 
with current recommendations (OECD Guideline 471) and an acceptable top concentration was 
achieved. 
In vitro micronucleus assay 
2-Acetyl-2-thiazoline [FL-no: 15.010] was tested for the induction of chromosome damage and 
potential aneugenic effects in an in vitro micronucleus assay using duplicate human peripheral blood 
lymphocytes prepared from pooled blood from two healthy male volunteers. Treatments were 
performed both in the absence and presence of Aroclor 1254 induced rat liver S9-mix (Watters, 2012).  
Cells were stimulated for 48 hours with phytohaemaglutinin to produce exponentially growing cells. 
A preliminary toxicity range-finding experiment was conducted with S9-mix and 3 hours treatment 
and without S9-mix with 3 and 24 hours treatment. Toxicity was evaluated as the effect of treatment 
on the Replication Index (RI). Twelve concentrations from 4.6 to 1262 μg/mL were tested. The 
concentrations selected for the main experiment were based on toxicity data from this preliminary test. 
In the main experiment, cells were treated for 3 hours, followed by 21 hours recovery (3 + 21 hours), 
with 0, 600, 1000 or 1292 μg/ml of 2-acetyl-2-thiazoline in the absence and in the presence of S9-mix. 
The levels of toxicity (reduction in RI) at the top concentration were 15 % and 0 % in the absence and 
presence of S-9, respectively. In a parallel assay, cells were treated for 24 hours (24 + 0 hours) with 0, 
100, 200, 400 or 600 μg/ml of 2-acetyl-2-thiazoline in the absence of S9-mix with no recovery period. 
The top concentration induced 55 % toxicity. Relevant positive and negative controls were included in 
all experiments. There were 2 replicate cultures per treatment, and 1000 binucleate cells per replicate 
(i.e., 2000 cells per dose) were scored for micronuclei. Thus, the study was conducted under GLP and 
the design complies with current recommendations (including OECD Guideline 487). No evidence of 
chromosomal damage or aneuploidy was observed as indicated by the lack of increased levels of 
micronucleated binucleate cells (MNBN) in the presence or absence of rat liver S9 metabolic 
activation (Table 5). 
In conclusion, 2-acetyl-2-thiazoline [FL-no: 15.010] did not induce micronuclei in male human 
peripheral blood lymphocyte cultures when tested for 3 + 21 hours in the presence of S9-mix and at up 
to toxic concentrations for 3 + 21 hours and 24 + 0 hours in the absence of S9-mix. 
For a summary of in vitro genotoxicity data on 2-acetyl-2-thiazoline [FL-no: 15.010], see Table 5. 
F
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4.4. EFSA Considerations 
No genotoxicity information was available on the 17 substances when evaluated by the JECFA in 
2008 (JECFA, 2008a), including the five substances considered in this Opinion. However, new in vitro 
genotoxicity studies (gene mutation test in bacteria and micronucleus assay in human peripheral blood 
lymphocytes) have become available on 2-acetyl-2-thiazoline [FL-no: 15.010], which is considered to 
be supporting for the other 2-thiazoline included in this FGE, 2-propionyl-2-thiazoline [FL-no: 
15.128]. 2-Acetyl-2-thiazoline [FL-no: 15.010] was negative in both assays and the Panel therefore 
concluded that 2-acetyl-2-thiazoline [FL-no: 15.010] and 2-propionyl-2-thiazoline [FL-no: 15.128] do 
not give rise to concern with respect to genotoxicity and can accordingly be evaluated using the 
Procedure. 
Two of these FGE.93 substances, 5-ethyl-4-methyl-2-(2-methylpropyl)-thiazoline [FL-no: 15.130] and 
5-ethyl-4-methyl-2-(2-butyl)-thiazoline [FL-no: 15.131], which are 3-thiazolines, are structurally 
similar to two other 3-thiazolines in FGE.21Rev1 for which the Panel has expressed a genotoxicity 
concern, and accordingly, the Procedure should not be applied to these two substances until adequate 
genotoxicity data become available. 
For the remaining substance 3-(methylthio)-methylthiophene [FL-no: 15.126], supported by FGE.21 
subgroup A-Ic, since no genotoxicity data were available on the substance, the Panel referred to the 
EFSA conclusion on the substances considered in group A-Ic in FGE.21Rev3 (EFSA, 2012b). For this 
subgroup A-Ic, EFSA had concluded that genotoxicity data were limited, but the data did not preclude 
evaluating the substances through the Procedure. The Panel concluded therefore, that the available 
data (from FGE.21Rev3) do not preclude taking 3-(methylthio)-methylthiophene [FL-no: 15.126] 
through the Procedure (done in previous version of FGE.93). 
5. APPLICATION OF THE PROCEDURE 
5.1. Application of the Procedure to Sulphur Containing Heterocyclic Compounds 
by the JECFA (JECFA, 2008a) 
According to JECFA, two of the substances belong to structural class II, and three to structural class 
III using the decision tree approach presented by Cramer et al. (Cramer et al., 1978). 
All five substances were concluded at step B4 in the JECFA Procedure – i.e. that the substances are 
not expected to be metabolised to innocuous products and that the estimated intakes are below the 
thresholds for their structural classes II and III. An adequate NOAEL was available for relevant 
structurally related substances for all five substances and the JECFA concluded that the substances are 
therefore not expected to be of safety concern when used as flavouring substances. 
In conclusion, the JECFA evaluated all five substances to be of no safety concern at the estimated 
levels of intake as flavouring substances based on the MSDI approach. 
The evaluations of the five sulphur containing heterocyclic substances are summarised in Table 6: 
Summary of Safety Evaluation of Sulphur Containing Heterocyclic Compounds (JECFA, 2008a)) 
5.2. Application of the Procedure to 59 Thiazoles, Thiophene, Thiazoline and 
Thienyl Derivatives and Miscellaneous Substances from Chemical Group 30 by 
EFSA (FGE.21Rev3) (EFSA, 2012b) 
Fifty-nine candidate substances were evaluated in FGE.21Rev3. Forty-eight substances were classified 
into structural class II and 11 into structural class III using the decision tree approach presented by 
Cramer et al. (1978).  
For seven substances the Procedure could not be applied due to indication of genotoxic potential in 
vitro [FL-no: 15.060, 15.086, 15.090, 15.099, 15.114, 15.119 and 15.133]. 
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The substances were allocated into structural subgroups (for description and explanation, see 
FGE.21Rev3 (EFSA, 2012b) and were evaluated at step B4 in the Procedure, i.e. the substances are 
not expected to be metabolised to innocuous products and the estimated intakes are below the 
thresholds for their structural classes II and III. 
In summary, the Panel concluded that 26 of the candidate substances evaluated through the Procedure, 
from the structural subgroups A-Ic (thiophenes with thiol-containing ring substituents) and A-II 
(thiazoles) are not of safety concern at their estimated levels of intake based on the MSDI approach, 
whereas for 26 candidate substances from the structural subgroups A-Ia (thiophene), A-Ib (thiophenes 
with non-thiol-containing ring substituents), A-III (benzothiazoles), B-I (dihydrothiophenes), B-IV 
(dithiazines) and B-VI (thiadiazine) additional data are required. 
The stepwise evaluations of the 59 substances are summarised in Table 7: Summary of Safety 
Evaluation Applying the Procedure (EFSA / FGE.21Rev3) (EFSA, 2012b). 
5.3. EFSA Considerations 
The Panel agrees with the way the application of the Procedure was applied by the JECFA for three of 
the five sulphur containing heterocyclic substances [FL-no: 15.010, 15.126 and 15.128].  
Two of these five substances, 5-ethyl-4-methyl-2-(2-methylpropyl)-thiazoline [FL-no: 15.130] and 5-
ethyl-4-methyl-2-(2-butyl)-thiazoline [FL-no: 15.131], which are 3-thiazolines, are structurally similar 
to two other 3-thiazolines in FGE.21Rev1 for which the Panel has expressed a genotoxicity concern, 
and accordingly the Procedure should not be applied to these two substances until adequate 
genotoxicity data become available. 
For 2-acetyl-2-thiazoline [FL-no: 15.010] and 2-propionyl-2-thiazoline [FL-no: 15.128], which are 2-
thiazolines, the intakes (MSDI) of 0.51 and 0.19 µg/capita/day are below the threshold for their 
structural class II. The NOAEL of 1.8 mg/kg bw per day for 2-acetyl-2-thiazoline from a 90-day and a 
52-week rat studies that examined a mixture of four flavouring substances including [FL-no: 15.010]  
(Munday and Kirkby, 1971; Munday and Kirkby, 1973) provides margins of safety of 2.1 x 105 and 
5.7 x 105 respectively, in relation to the estimated levels of exposure from their use as flavouring 
substances. The Panel agrees that this provides sufficient safety margins and that these flavouring 
substances can be concluded at step B4 in the Procedure to be of no safety concern. The studied 
mixture included also 3-hydroxy-4,5-dimethylfuran-2(5H)-one [Fl.no: 10.030] and was used by the 
Panel to support the substances in FGE.10Rev3 (EFSA CEF Panel, 2012c). 
For 3-(methylthio)-methylthiophene [FL-no: 15.126], allocated to subgroup A-Ic, the intake (MSDI) 
of 0.12 µg/capita/day is below the threshold for its structural class III. The Panel agrees with the 
JECFA, and in line with the conclusion reached by EFSA for subgroup A-Ic in FGE.21Rev3, that an 
adequate NOAEL provides a sufficient safety margin and that this flavouring substance can be 
concluded at step B4 in the Procedure as of no safety concern. 
CONCLUSION 
In Flavouring Group Evaluation 93 (FGE.93), the EFSA considered six flavouring substances from a 
group of flavouring substances consisting of sulphur-containing heterocyclic substances evaluated by 
the JECFA at its 68th meeting. This revision is made due to additional available genotoxicity data on 2-
acetyl-2-thiazoline [FL-no: 15.010], as requested in previous version of FGE.93. For one substance 
[FL-no: 15.127], additional toxicity data was requested in FGE.93. However, since publication of 
FGE.93, the substance [FL-no: 15.127] is no longer supported by Industry for use as a flavouring 
substance in Europe and will therefore not be considered any further. Therefore, the present revision 
of FGE.93, FGE.93Rev1, considers five flavouring substances evaluated by the JECFA.  
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The Panel concluded that all the five substances from the JECFA flavouring group of sulphur 
containing heterocyclic substances are structurally related to the 59 substances evaluated by EFSA in 
FGE.21Rev3.  
The Panel agrees with the way the application of the Procedure was applied by the JECFA for three of 
the five substances, 2-acetyl-2-thiazoline [FL-no: 15.010], 3-(methylthio)-methylthiophene [FL-no: 
15.126] and 2-propionyl-2-thiazoline [FL-no: 15.128]. The remaining two substances, 5-ethyl-4-
methyl-2-(2-methylpropyl)-thiazoline [FL-no: 15.130] and 5-ethyl-4-methyl-2-(2-butyl)-thiazoline 
[FL-no: 15.131], which are 3-thiazolines, are structurally similar to two other 3-thiazolines in FGE.21 
for which the Panel has expressed a genotoxicity concern, and accordingly the Procedure should not 
be applied to these two substances until adequate genotoxicity data become available. 
Genotoxicity data have become available for 2-acetyl-2-thiazoline [FL-no: 15.010] and based on these 
new in vitro studies (gene mutation test in bacteria and micronucleus assay in human peripheral blood 
lymphocytes), the genotoxicity concern could be ruled out. 2-Acetyl-2-thiazoline [FL-no: 15.010] is 
supporting the other 2-thiazoline included in this FGE, 2-propionyl-2-thiazoline [FL-no: 15.128], so 
the two substances can now be evaluated using the Procedure.  
For 2-acetyl-2-thiazoline [FL-no: 15.010] and 2-propionyl-2-thiazoline [FL-no: 15.128] (2-thiazolines) 
the intakes (MSDI) of 0.51 and 0.19 µg /capita/day are below the threshold for their structural class II. 
The NOAEL of 1.8 mg/kg bw per day for 2-acetyl-2-thiazoline from a 90-day and a 52-week rat 
studies that examined a mixture of four flavouring substances, including [FL-no: 15.010], provides 
margins of safety of 2.1 x 105 and 5.7 x 105, respectively, in relation to the estimated levels of 
exposure from their use as flavouring substances. The Panel agrees that this provides sufficient safety 
margins and that these flavouring substances can be evaluated at step B4 in the Procedure as being of 
no safety concern. 
For 3-(methylthio)methylthiophene [FL-no: 15.126], the Maximised Survey-derived Daily Intake 
(MSDI) is below the threshold for its structural class (Cramer class III, 90 µg/person/day). The Panel 
agrees with the JECFA that the NOAEL of 0.29 mg/kg bw/day for the supporting substance 2-thienyl 
disulfide [FL-no: 15.008] is adequate for [FL-no: 15.126] and that it provides a sufficient safety 
margin. It can therefore be concluded that this substance is of no safety concern when used as 
flavouring substance at the estimated level of intake, based on the MSDI approach. 
For the three substances [FL-no: 15.010, 15.126 and 15.128] evaluated through the Procedure, use 
levels have been provided by the Industry. The mTAMDI figures calculated for the substances [FL-no: 
15.010 and 15.128] in structural class II are 810 and 62 µg/person/day, respectively. For substance 
[FL-no: 15.010] the value exceeds the threshold of 540 µg/person/day for structural class II. For the 
substance [FL-no: 15.126] in structural class III the mTAMDI figure is 3.8 µg/person/day, which is 
below the threshold of concern of 90 µg/person/day. Although the two remaining substances [FL-no: 
15.130 and 15.131] cannot be evaluated through the Procedure, the corresponding available use levels 
were considered. For the two substances in structural class III the figures are 160 µg/person/day, 
which exceeds the threshold of concern of 90 microgram/person/day for its structural class. Thus, for 
three substances [FL-no: 15.010, 15.130 and 15.131] the intakes, estimated on the basis of the 
mTAMDI approach, exceed the threshold for their structural classes. Therefore more reliable exposure 
data are required. On the basis of such additional data, these flavouring substances should be 
considered using the Procedure. Subsequently, additional data might become necessary.  
In order to determine whether the conclusion for the five JECFA evaluated substances can be applied 
to the materials of commerce, it is necessary to consider the available specifications. Adequate 
specifications including complete purity criteria and identity tests are available for all JECFA-
evaluated substances. 
Thus, the Panel concluded that three substances [FL-no: 15.010, 15.126 and 15.128] are of no safety 
concern at the estimated intake. For the remaining two substances [FL-no: 15.130 and 15.131] the 
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Panel concluded that the Procedure could not be applied pending submission and evaluation of 
genotoxicity data. 
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SUMMARY OF GENOTOXICITY DATA  
Table 4:  Genotoxicity Data (in vitro) EFSA / FGE.21Rev3 (EFSA, 2012b) 
Chemical Name  Test System Test Object  Concentration Result  Reference  Comments 
Subgroup A-Ia 
Thiophene [15.106] Ames assay  
(plate 
incorporation 
method) 
S. typhimurium 
TA98; TA100; 
TA1535; 
TA1537 
3 µmol/plate (all 
strains) 
(252 µg/plate) 
Negative
(±S9) 
(Florin et al., 1980) Published non-GLP study. Qualitative 
screening in a spot-test with three strains, 
quantitative study (4 doses, 0.03, 0.3, 3, 30 
µmol/plate) with TA100 only. Limited report 
of experimental details and results. Insufficient 
quality, study not considered adequate for the 
evaluation of mutagenic activity. 
Ames assay  
(preincubation 
method) 
S. typhimurium 
TA97;TA98; 
TA100; 
TA1535; 
TA1537 
Up to 10,000 
µg/plate  
Negative 
(±S9)1 
(Zeiger et al., 1987) Non-GLP study roughly in accordance with 
OECD Guideline 471. The study is considered 
valid. 
Ames assay  
(preincubation 
method) 
S. typhimurium 
TA98; TA100; 
TA102 
0.01-1.2 
mmol/plate  
(100,968 µg/plate) 
Negative
(±S9) 
(Aeschbacher et al., 1989) Greatest effects are quantified by ”mutation 
factor,” no numbers are given for negative 
results. Limited quality (only 3 strains used), 
but otherwise acceptable study.  
Ames assay  
(plate 
incorporation 
method) 
S. typhimurium 
TA98; TA100 
Up to 100 
µmol/plate 
(8414 µg/plate) 
Negative
(±S9) 
(Lee et al., 1994) Only two strains used but otherwise acceptable 
study. 
Ames assay S. typhimurium 
TA98, TA100, 
TA1535, 
TA1537 
0, 78.1, 156, 313, 
625, 1250 µg/plate 
Negative
(±S9) 
(Shibuya, 2006) Valid study according to OECD Test 
Guidelines and Guidelines for screening 
mutagenicity testing of chemicals (Japan), 
provided as a translation of the original report 
in Japanese. 
 E. coli WP2 
uvrA 
0, 78.1, 156, 313, 
625, 1250, 2500, 
5000 µg/plate 
Negative
(±S9) 
  
Chromosomal 
Abberation 
Chinese hamster 
lung cells 
0, 210, 420, 840 
µg/ml 
Negative
(±S9) 
(Tanaka, 2006) Valid study according to Guidelines for 
screening mutagenicity testing of chemicals 
(Japan), provided as a translation of the 
original report in Japanese. 
Subgroup A-Ib 
2-Methylthiophene 
[15.091] 
Ames assay  
(preincubation 
S. typhimurium 
TA98; TA100; 
0.00001 - 1.0 
mmol/plate  
Negative
(±S9) 
(Aeschbacher et al., 1989) Greatest effects are quantified by ”mutation 
factor,” no numbers are given for negative 
Flavouring Group Evaluation 93, Revision 1
 
EFSA Journal 2013;11(11):3452 22
Table 4:  Genotoxicity Data (in vitro) EFSA / FGE.21Rev3 (EFSA, 2012b) 
Chemical Name  Test System Test Object  Concentration Result  Reference  Comments 
method) TA102 (98,170 µg/plate) results. Limited quality (only 3 strains used), 
but otherwise acceptable study.  
Ames assay  
(plate 
incorporation 
method) 
S. typhimurium 
TA98; TA100 
Up to 100 
µmol/plate 
(9817 µg/plate) 
Negative
(±S9) 
(Lee et al., 1994) Only two strains used but otherwise acceptable 
study. 
3-Methylthiophene 
[15.092] 
Ames assay  
(preincubation 
method) 
S. typhimurium 
TA98; TA100; 
TA102 
0.01-1.0 
mmol/plate  
(98,170 µg/plate) 
Negative
(±S9) 
(Aeschbacher et al., 1989) Greatest effects are quantified by ”mutation 
factor,” no numbers are given for negative 
results. Limited quality (only 3 strains used), 
but otherwise acceptable study.  
Ames assay  
(plate 
incorporation 
method) 
S. typhimurium 
TA98; TA100 
Up to 100 
µmol/plate 
(9817 µg/plate) 
Negative
(±S9) 
(Lee et al., 1994) Only two strains used but otherwise acceptable 
study. 
2,5-Dimethylthiophene 
[15.064] 
Ames assay  
(plate 
incorporation 
method) 
S. typhimurium 
TA98; TA100 
Up to 100 
µmol/plate 
(11,219 µg/plate) 
Negative
(±S9) 
(Lee et al., 1994) Only two strains used but otherwise acceptable 
study. 
2-Acetylthiophene 
[15.040] 
Ames assay  
(plate 
incorporation 
method) 
S. typhimurium 
TA98; TA100 
Up to 100 
µmol/plate 
(12,618 µg/plate) 
Negative
(±S9) 
(Lee et al., 1994) Only two strains used but otherwise acceptable 
study. 
 SOS Chromotest E. coli NR  Negative with rat S9,  
positive without rat 
S9 
(Mosier et al., 2003) Study endpoint inappropriate for the estimation 
of genotoxic potential. 
2-Acetyl-3-
Methylthiophene 
[15.037] 
SOS Chromotest E. coli NR Negative with rat S9,  
positive without rat 
S9 
(Mosier et al., 2003) Study endpoint inappropriate for the estimation 
of genotoxic potential.  
Thiophene-2-
carbaldehyde [15.107] 
SOS Chromotest E. coli NR Negative with rat S9,  
positive without rat 
S9 
(Mosier et al., 2003) Study endpoint inappropriate for the estimation 
of genotoxic potential. 
5-Ethylthiophene-2-
carbaldehyde [15.074] 
SOS Chromotest E. coli NR Negative with rat S9,  
positive without rat 
S9 
(Mosier et al., 2003) Study endpoint inappropriate for the estimation 
of genotoxic potential. 
(5-Methyl-2-
thiophenecarbaldehyde 
[15.004]) 
Ames assay  
(plate 
incorporation 
method) 
S. typhimurium 
TA98; TA100 
Up to 100 
µmol/plate 
(12,618 µg/plate) 
Negative
(±S9) 
(Lee et al., 1994) Only two strains used but otherwise acceptable 
study. 
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Table 4:  Genotoxicity Data (in vitro) EFSA / FGE.21Rev3 (EFSA, 2012b) 
Chemical Name  Test System Test Object  Concentration Result  Reference  Comments 
Subgroup A-II 
2,4-Dimethylthiazole 
[15.062] 
Ames assay  
(plate 
incorporation 
method) 
S. typhimurium 
TA100 
9.3 and 94 mmol/l 
top agar 
(10,639 µg/ml) 
Negative
(-S9) 
(Voogd et al., 1983) Insufficient quality (one test strain as well as 
without metabolic activation only).  
(4,5-Dimethylthiazole 
[15.017]) 
Ames assay  
(plate 
incorporation 
method) 
S. typhimurium 
TA98; TA100 
Up to 100 
µmol/plate 
(11,318 µg/plate) 
Negative
(±S9) 
(Lee et al., 1994) Only two strains used but otherwise acceptable 
study. 
(4-Methylthiazole 
[15.035]) 
Ames assay  
(plate 
incorporation 
method) 
S. typhimurium 
TA98; TA100 
Up to 100 
µmol/plate 
(9916 µg/plate) 
Negative
(±S9) 
(Lee et al., 1994) Only two strains used but otherwise acceptable 
study. 
Subgroup A-III 
2-Methyl-4,5-
benzothiazole [15.088] 
Ames assay  
(plate 
incorporation 
method) 
S. typhimurium 
TA98; TA100; 
TA102; 
TA1535; 
TA1537 
100-10,000 
µg/plate  
Negative 
(±S9)1 
(Longfellow, 1998) Summary report of NCI-short-term test 
program, results not given in detail. 
(Benzothiazole 
[15.016]) 
Ames assay S. typhimurium 
TA98; TA100; 
TA1535; 
TA1537 
Up to 5000 
µg/plate   
Negative
(±S9) 
(Bayer, 1991) Summary in IUCLID data set only. According 
to this summary, the assay was in compliance 
with GLP; accordance with OECD Guideline 
471 not stated. 
Mouse 
lymphoma assay 
Mouse 
L5178Y tk+/- 
cells 
10-250 µg/ml  Negative
(±S9) 
(Longfellow, 1997) Summary report of NCI-short-term test 
program, results not given in detail. 
Subgroup B-III 
2-Propylthiazolidine 
[15.099] 
Ames assay S. typhimurium 
TA98; TA100 
1, 10, 100 µg/ml  1 and 10 µg/ml: 
positive in TA100 
(±S9); 
100 µg/ml: positive 
in TA98 and 
TA100.(±S9) 
(Mihara and Shibamoto, 
1980) 
The results were stated to be positive, 
however, the magnitude and a positive dose 
effect relationship could not be assessed (no 
numbers are given). 
2-Methylthiazolidine 
[15.090] 
Ames assay S. typhimurium 
TA98; TA100 
1, 10, 100 µg/ml  1 and 10 µg/ml: 
positive in TA100; 
(±S9) 
100 µg/ml: positive 
(Mihara and Shibamoto, 
1980) 
The results were stated to be positive, 
however, the magnitude and a positive dose 
effect relationship could not be assessed (no 
numbers are given). 
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Table 4:  Genotoxicity Data (in vitro) EFSA / FGE.21Rev3 (EFSA, 2012b) 
Chemical Name  Test System Test Object  Concentration Result  Reference  Comments 
in TA98 and TA100 
(±S9) 
(2-Ethylthiazolidine) Ames assay S. typhimurium 
TA98; TA100 
1, 10, 100 µg/ml  1 µg/ml: positive in 
TA100 (±S9) and 
TA98 (-S9); 
10 µg/ml: positive in 
TA100 (±S9);  
100 µg/ml: positive 
TA98 and 
TA100.(±S9) 
(Mihara and Shibamoto, 
1980) 
The results were stated to be positive, 
however, the magnitude and a positive dose 
effect relationship could not be assessed (no 
numbers are given). 
(2-
Isopropylthiazolidine) 
Ames assay S. typhimurium 
TA98; TA100 
1, 10, 100 µg/ml  1 and 10 µg/ml: 
positive in TA100 
(±S9);  
100 µg/ml: positive 
in TA100 (±S9) and 
TA98 (-S9) 
(Mihara and Shibamoto, 
1980) 
The results were stated to be positive, 
however, the magnitude and a positive dose 
effect relationship could not be assessed (no 
numbers are given). 
(2-Butylthiazolidine) Ames assay S. typhimurium 
TA98; TA100 
1, 10, 100 µg/ml  1 µg/ml: positive in 
TA100 (+S9);  
10 µg/ml: positive in 
TA100 (±S9);  
100 µg/ml: positive 
in TA100 (±S9) and 
TA98 (-S9) 
(Mihara and Shibamoto, 
1980) 
The results were stated to be positive, 
however, the magnitude and a positive dose 
effect relationship could not be assessed (no 
numbers are given). 
(2-Isobutylthiazolidine) Ames assay S. typhimurium 
TA98; TA100 
1, 10, 100 µg/ml  1 µg/ml: positive in 
TA98 and TA100 
(+S9);  
10 µg/ml: positive in 
TA98 and TA100 
(±S9);  
100 µg/ml: positive 
in TA98 and TA100 
(±S9)  
(Mihara and Shibamoto, 
1980) 
The results were stated to be positive, 
however, the magnitude and a positive dose 
effect relationship could not be assessed (no 
numbers are given). 
NR: Not reported. 
1 With and without rat and hamster S9 metabolic activation. 
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Table 5:  Summary of Additional Genotoxicity Data on 2-Acetyl-2-thiazoline Submitted by Industry 
FL-no 
JECFA
-no 
EU Register name 
JECFA name 
Structural 
formula 
End-point Test system Concentration Results Reference Comments 
15.010 
1759 
2-Acetyl-2-thiazoline S
N
O
 
Reverse 
mutation 
Salmonella 
typhimurium 
TA98, 
TA100, 
TA1535, 
TA1537 and 
TA102 
5, 15.81, 50, 158.1, 
500, 
1581 and 5000 
μg/plate1 
Negative (Mc Garry, 
2012) 
Valid study conducted according to 
current guidelines. 
156.3, 312.5, 625.0, 
1250, 
2500 and 5000 μg 
/plate1,2 
Negative Valid study conducted according to 
current guidelines. 
Micronucleus 
induction 
Human 
peripheral 
blood 
lymphocytes 
600, 1000 and 1292 
μg /ml3 
600, 1000 and 1292 
μg /ml4 
Negative (Watters, 
2012) 
Valid study conducted according to 
current guidelines. 
100, 200, 400 and 600 
μg /ml5 
Negative Valid study conducted according to 
current guidelines. 
1 With and without metabolic activation.  
2 Assay modified with pre-incubation in the presence of S9. 
3 Without metabolic activation, 3 hours treatment +21 hours recovery. 
4 With metabolic activation, 3 hours treatment + 21 hours recovery. 
5 Without metabolic activation, 24 hours + 0 hours recovery.
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SUMMARY OF SAFETY EVALUATIONS 
Table 6:  Summary of Safety Evaluation by the JECFA (JECFA, 2008a) 
FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
Class 2) 
Evaluation 
procedure path 3) 
Outcome on the 
named compound 
[4) or 5)] 
EFSA conclusion on 
the named compound 
(Procedure steps, 
intake estimates, 
NOAEL, genotoxicity) 
EFSA 
conclusion on 
the material of 
commerce 
15.010 
1759 
2-Acetyl-2-thiazoline S
N
O
 
0.51 
ND 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety 
concern at the 
estimated level of 
intake based on 
the MSDI 
approach. 
15.127 
1750 
1-(3-Hydroxy-5-methyl-
2-thienyl)ethanone S
OH
O
 
0.012 
ND 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) No longer supported by 
Industry, EFSA 2011. 
No longer 
supported by 
Industry (EFSA 
2011). 
15.128 
1760 
2-Propionyl-2-
thiazoline 
N
S
O
 
0.19 
ND 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety 
concern at the 
estimated level of 
intake based on 
the MSDI 
approach. 
15.126 
1765 
3-(Methylthio)-
methylthiophen 
S
S  
0.012 
ND 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) No safety concern at the 
estimated level of intake 
based on the MSDI 
approach. 
No safety 
concern at the 
estimated level of 
intake based on 
the MSDI 
approach. 
Register name to 
be changed to 3-
(methylthio)-
methylthiophene. 
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Table 6:  Summary of Safety Evaluation by the JECFA (JECFA, 2008a) 
FL-no 
JECFA-
no 
EU Register name Structural formula EU MSDI 1)  
US MSDI 
(μg/capita/day) 
Class 2) 
Evaluation 
procedure path 3) 
Outcome on the 
named compound 
[4) or 5)] 
EFSA conclusion on 
the named compound 
(Procedure steps, 
intake estimates, 
NOAEL, genotoxicity) 
EFSA 
conclusion on 
the material of 
commerce 
15.130 
1761 
5-Ethyl-4-methyl-2-(2-
methylpropyl)-
thiazoline 
S
N
 
0.012 
ND 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) Genotoxicity data 
required. 
 
15.131 
1762 
5-Ethyl-4-methyl-2-(2-
butyl)-thiazoline 
S
N
 
0.012 
ND 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) Genotoxicity data 
required. 
 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800 µg/person/day, Class II = 540 µg/person/day, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
ND not determined. 
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Table 7:  Summary of Safety Evaluation by the EFSA (FGE.21Rev3) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day) 
Class 2) 
Evaluation 
procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on 
the material of 
commerce [6), 
7), or 8)] 
Evaluation 
remarks 
15.037 
 
2-Acetyl-3-
methylthiophene S
O 0.18 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required  a) 
15.038 
 
2-Acetyl-4-
methylthiazole 
N
S
O 0.0049 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.039 
 
2-Acetyl-5-
methylthiazole 
N
S
O
 
0.0024 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.040 
 
2-Acetylthiophene 
S
O
 
2.2 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
15.043 
 
2-Butyl-5-
ethylthiophene 
S
 
0.0012 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
15.044 
 
2-Butylthiazole 
N
S
 
0.011 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.045 
 
2-Butylthiophene S
 
0.012 
 
Class II 
B3: Intake below 
threshold,  
Additional data required   
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Table 7:  Summary of Safety Evaluation by the EFSA (FGE.21Rev3) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day) 
Class 2) 
Evaluation 
procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on 
the material of 
commerce [6), 
7), or 8)] 
Evaluation 
remarks 
B4: No adequate 
NOAEL 
15.050 
 
2,5-Diethyl-4-
methylthiazole 
N
S
 
0.012 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.051 
 
2,5-Diethyl-4-
propylthiazole 
N
S 0.0012 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.052 
 
2,5-Diethylthiazole 
N
S
 
0.015 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.054 
 
Dihydro-2,4,6-triethyl-
1,3,5(4H)-dithiazine 
S NH
S 0.0012 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
15.058 
 
4,5-Dimethyl-2-
ethylthiazole 
N
S
 
0.015 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.061 
 
2,5-Dimethyl-4-
ethylthiazole 
N
S
 
0.011 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
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Table 7:  Summary of Safety Evaluation by the EFSA (FGE.21Rev3) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day) 
Class 2) 
Evaluation 
procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on 
the material of 
commerce [6), 
7), or 8)] 
Evaluation 
remarks 
15.062 
 
2,4-Dimethylthiazole 
N
S
 
0.61 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.063 
 
2,5-Dimethylthiazole 
N
S
 
0.0061 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.064 
 
2,5-Dimethylthiophene S
 
0.23 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
15.067 
 
4-Ethyl-2-
methylthiazole 
N
S
 
0.0037 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.068 
 
5-Ethyl-2-
methylthiazole 
N
S
 
0.0061 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.069 
 
4-Ethyl-5-
methylthiazole 
N
S
 
0.012 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.070 
 
2-Ethyl-5-
methylthiophene 
S
 
0.061 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
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Table 7:  Summary of Safety Evaluation by the EFSA (FGE.21Rev3) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day) 
Class 2) 
Evaluation 
procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on 
the material of 
commerce [6), 
7), or 8)] 
Evaluation 
remarks 
15.071 
 
2-Ethylthiazole 
N
S
 
0.028 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.072 
 
2-Ethylthiophene S
 
0.0012 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
15.074 
 
5-Ethylthiophene-2-
carbaldehyde S
O
 
0.0012 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
15.076 
 
2-Hexylthiophene S
 
0.12 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
15.078 
 
2-Isobutyl-4,5-
dimethylthiazole 
N
S
 
0.12 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.080 
 
2-Isopropyl-4,5-
dimethylthiazole 
N
S
0.012 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.084 
 
5-Methyl-2-
pentylthiazole 
N
S
 
0.0037 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
4) 6)  
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Table 7:  Summary of Safety Evaluation by the EFSA (FGE.21Rev3) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day) 
Class 2) 
Evaluation 
procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on 
the material of 
commerce [6), 
7), or 8)] 
Evaluation 
remarks 
NOAEL exists 
15.085 
 
4-Methyl-2-
propionylthiazole 
N
S
O 0.0037 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.089 
 
2-Methylthiazole 
N
S
 
0.018 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.091 
 
2-Methylthiophene S
 
0.019 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
15.092 
 
3-Methylthiophene S
 
0.12 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
15.093 
 
2-Octylthiophene S
 
0.012 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
15.094 
 
2-Pentanoylthiophene 
S
O
 
0.0012 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required  a) 
15.096 
 
sec-Pentylthiophene S
 
0.24 
 
Class II 
B3: Intake below 
threshold,  
Additional data required   
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Table 7:  Summary of Safety Evaluation by the EFSA (FGE.21Rev3) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day) 
Class 2) 
Evaluation 
procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on 
the material of 
commerce [6), 
7), or 8)] 
Evaluation 
remarks 
B4: No adequate 
NOAEL 
15.097 
 
2-Propionylthiophene 
S
O
 
0.12 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
15.098 
 
2-Propylthiazole 
N
S
 
0.085 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.107 
 
Thiophene-2-
carbaldehyde S
O
 
0.21 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required  a) 
15.115 
 
2-Isobutyl-4-methyl 
thiazole 
N
S
 
0.011 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.116 
 
2-Acetyl-4-
ethylthiazole 
N
S
O 0.024 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.118 
 
4-Butylthiazole 
N
S 1.3 
 
Class II 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
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Table 7:  Summary of Safety Evaluation by the EFSA (FGE.21Rev3) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day) 
Class 2) 
Evaluation 
procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on 
the material of 
commerce [6), 
7), or 8)] 
Evaluation 
remarks 
15.129 
 
Tetrahydro-2,4,6-
trimethyl-1,3,5(2H)-
thiadiazine HN NH
S 0.61 
 
Class II 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required  a) 
15.060 
 
2,4-Dimethyl-3-
thiazoline 
N
S 0.012 
 
Class II 
No evaluation 
  b) 
15.086 
 
2-Methyl-2-thiazoline 
N
S 0.24 
 
Class II 
No evaluation 
  b) 
15.090 
 
2-Methylthiazolidine 
NH
S 0.024 
 
Class II 
No evaluation 
  c) 
15.099 
 
2-Propylthiazolidine 
NH
S 0.012 
 
Class II 
No evaluation 
  c) 
15.119 
 
2-Isobutyl-3-thiazoline 
N
S 0.011 
 
Class II 
No evaluation 
  b) 
15.042 
 
2-Butyl-4-
methyl(4H)pyrrolidino[
1,2d]-1,3,5-dithiazine S N
S 0.0012 
 
Class III 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required  a) 
15.055 
 
2,4-
Dimethyl(4H)pyrrolidin
o[1,2e]-1,3,5-dithiazine S N
S
0.055 
 
Class III 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
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Table 7:  Summary of Safety Evaluation by the EFSA (FGE.21Rev3) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day) 
Class 2) 
Evaluation 
procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on 
the material of 
commerce [6), 
7), or 8)] 
Evaluation 
remarks 
15.057 
  
4,6-Dimethyl-2-(1-
methylethyl)dihydro-
1,3,5-dithiazine S
N
H
S
1.5 
 
Class III 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
15.077 
 
4-Hydroxy-2,5-
dimethylthiophen-
3(2H)-one 
S
HO O  
0.12 
 
Class III 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required  a) 
15.079 
 
2-Isobutyldihydro-4,6-
dimethyl-1,3,5-
dithiazine S
N
H
S
5.7 
 
Class III 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
15.082 
 
3-Mercaptothiophene S
SH  
0.011 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.087 
 
2-Methyl-3-
mercaptothiophene 
S
SH  
0.12 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.088 
 
2-Methyl-4,5-
benzothiazole 
N
S
 
0.0085 
 
Class III 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required  a) 
15.106 
 
Thiophene S
 
0.12 
 
Class III 
B3: Intake below 
threshold,  
Additional data required   
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Table 7:  Summary of Safety Evaluation by the EFSA (FGE.21Rev3) (EFSA CEF Panel, 2012b) 
FL-no EU Register name Structural formula MSDI 1) 
(μg/capita/day) 
Class 2) 
Evaluation 
procedure path 3) 
Outcome on the 
named compound 
[ 4) or 5] 
Outcome on 
the material of 
commerce [6), 
7), or 8)] 
Evaluation 
remarks 
B4: No adequate 
NOAEL 
15.108 
 
2-
Thiophenemethanethiol 
S
SH
 
0.0073 
 
Class III 
B3: Intake below 
threshold,  
B4: Adequate 
NOAEL exists 
4) 6)  
15.135 
 
Ethyl thialdine 0.61 
 
Class III 
B3: Intake below 
threshold,  
B4: No adequate 
NOAEL 
Additional data required   
15.114 
 
5-Acetyl-2,3-dihydro-
1,4-thiazine 
N
H
S
O 0.012 
 
Class III 
No evaluation 
  c) 
15.133 
 
5-Acetyl-2,3-dihydro-
1,4-thiazine 
S
N
H
O
0.61 
 
Class III 
No evaluation 
  c) 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800, Class II = 540, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products. Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
6) No safety concern at the estimated level of intake of the material of commerce meeting the specification requirement (based on intake calculated by the MSDI approach). 
7) Tentatively regarded as presenting no safety concern (based on intake calculated by the MSDI approach) pending further information on the purity of the material of commerce and/or 
information on stereoisomerism. 
8) No conclusion can be drawn due to lack of information on the purity of the material of commerce. 
S
N
H
S
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a) Substance not supported by Industry (EFFA, 2009). 
b) Genotoxic potential in vitro. 
c) Genotoxic potential in vitro. Substance not supported by Industry (EFFA, 2009). 
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ABBREVIATIONS 
BW  Body Weight 
CAS  Chemical Abstract Service 
CEF  Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
CHO  Chinese hamster ovary (cells) 
CoE  Council of Europe 
DNA  Deoxyribonucleic acid 
EFFA  European Flavour and Fragrance Association 
EFSA  The European Food Safety Authority 
EPA  United States Environmental Protection Agency  
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GLP  Good laboratory practice 
ID  Identity 
IR  Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
MNBN  Micronucleated Binucleate cells 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NCE  Normochromatic erythrocyte 
No  Number 
NOAEL No Observed Adverse Effect Level 
OECD  Organisation for Economic Co-operation and Development 
PCE  Polychromatic erythrocyte 
RI  Replication Index 
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SCF  Scientific Committee on Food 
WHO  World Health Organisation 
